Previous Blogs

last year, an expert from CFDA Jinan Quality Inspection Center for Pharmaceutical Packaging Materials spoke about preparation of a guidance for stability studies.

By Lynn Yao

January 26, 2018

In 2016, the China Federal Drug Administration (CFDA) made two announcements regarding packaging of parenteral drug products. Per these announcements, stability studies of packaging materials should refer to protection, compatibility, safety and functionality properties.

West Ready Pack

By Kristine Davidson

January 22, 2015

One of the most  important aspects for choosing  container closure system for parenteral drug products  is to ensure an ideal fit between all components to maintain product sterility.